Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 324

1.

Minimal Change Nephrotic Syndrome Sequentially Complicated by Acute Kidney Injury and Painful Skin Ulcers due to Calciphylaxis.

Sato R, Akimoto T, Imai T, Nakagawa S, Okada M, Miki A, Takeda S, Yamamoto H, Saito O, Muto S, Kusano E, Nagata D.

Intern Med. 2016;55(22):3315-3320.

2.
3.

A Supraglottic Pseudotumor in an Immunocompromised Patient with Nephrotic Syndrome, Herpes Zoster, and a Cytomegalovirus Infection.

Akimoto T, Yamazaki T, Saito O, Muto S, Kusano E, Nagata D.

Clin Med Insights Case Rep. 2016 Aug 8;9:61-5. doi: 10.4137/CCRep.S40058.

4.

Bowel Obstruction and Peritoneal Dialysis: A Case Report of a Patient with Complications from a Broad Ligament Hernia.

Otani-Takei N, Akimoto T, Sadatomo A, Saito O, Muto S, Kusano E, Nagata D.

Clin Med Insights Case Rep. 2016 Aug 8;9:57-60. doi: 10.4137/CCRep.S40059.

5.

Effect of Behavior Modification on Outcome in Early- to Moderate-Stage Chronic Kidney Disease: A Cluster-Randomized Trial.

Yamagata K, Makino H, Iseki K, Ito S, Kimura K, Kusano E, Shibata T, Tomita K, Narita I, Nishino T, Fujigaki Y, Mitarai T, Watanabe T, Wada T, Nakamura T, Matsuo S; Study Group for Frontier of Renal Outcome Modifications in Japan (FROM-J)..

PLoS One. 2016 Mar 21;11(3):e0151422. doi: 10.1371/journal.pone.0151422.

6.

Matrix metalloproteinase-2 as a superior biomarker for peritoneal deterioration in peritoneal dialysis.

Hirahara I, Kusano E, Morishita Y, Inoue M, Akimoto T, Saito O, Muto S, Nagata D.

World J Nephrol. 2016 Mar 6;5(2):204-12. doi: 10.5527/wjn.v5.i2.204.

7.

Effluent Tenascin-C Levels Reflect Peritoneal Deterioration in Peritoneal Dialysis: MAJOR IN PD Study.

Hirahara I, Kusano E, Imai T, Morishita Y, Inoue M, Akimoto T, Saito O, Muto S, Nagata D.

Biomed Res Int. 2015;2015:241098. doi: 10.1155/2015/241098.

8.

[Comparison of benefits to non-dialysis CKD patients between darbepoetin alpha and epoetin beta pegol].

Ito C, Akimoto T, Morishita Y, Yamamoto H, Ogura M, Yamazaki T, Miki A, Homma S, Kusano E, Asano Y, Nagata D.

Nihon Jinzo Gakkai Shi. 2015;57(7):1233-40. Japanese.

PMID:
26665615
9.

Association between Serum Soluble Klotho Levels and Mortality in Chronic Hemodialysis Patients.

Otani-Takei N, Masuda T, Akimoto T, Honma S, Watanabe Y, Shiizaki K, Miki T, Kusano E, Asano Y, Kuro-O M, Nagata D.

Int J Endocrinol. 2015;2015:406269. doi: 10.1155/2015/406269.

10.

Attenuation of methylglyoxal-induced peritoneal fibrosis: immunomodulation by interleukin-10.

Onishi A, Akimoto T, Urabe M, Hirahara I, Muto S, Ozawa K, Nagata D, Kusano E.

Lab Invest. 2015 Dec;95(12):1353-62. doi: 10.1038/labinvest.2015.110.

11.

Antineutrophil Cytoplasmic Antibody-associated Glomerulonephritis Complicated by Pneumatosis Intestinalis.

Nakagawa S, Akimoto T, Takeda S, Okada M, Miki A, Yamamoto H, Muto S, Kusano E, Nagata D.

Clin Med Insights Case Rep. 2015 Aug 10;8:65-70. doi: 10.4137/CCRep.S26155.

12.

Impact of Renal Transplantation and Nephrectomy on Urinary Soluble Klotho Protein.

Kimura T, Akimoto T, Watanabe Y, Kurosawa A, Nanmoku K, Muto S, Kusano E, Yagisawa T, Nagata D.

Transplant Proc. 2015 Jul-Aug;47(6):1697-9. doi: 10.1016/j.transproceed.2015.06.025.

PMID:
26293036
13.

[Development of an action scale to show the necessity of healthcare activities].

Okamoto R, Hatono Y, Koide K, Nagano F, Iwamoto S, Kusano E.

Nihon Koshu Eisei Zasshi. 2015;62(6):271-80. doi: 10.11236/jph.62.6_271. Japanese.

14.

Prevalence of Fabry disease in dialysis patients: Japan Fabry disease screening study (J-FAST).

Saito O, Kusano E, Akimoto T, Asano Y, Kitagawa T, Suzuki K, Ishige N, Akiba T, Saito A, Ishimura E, Hattori M, Hishida A, Guili C, Maruyama H, Kobayashi M, Ohashi T, Matsuda I, Eto Y.

Clin Exp Nephrol. 2016 Apr;20(2):284-93. doi: 10.1007/s10157-015-1146-7.

PMID:
26197777
15.

Methylglyoxal Induced Basophilic Spindle Cells with Podoplanin at the Surface of Peritoneum in Rat Peritoneal Dialysis Model.

Hirahara I, Sato H, Imai T, Onishi A, Morishita Y, Muto S, Kusano E, Nagata D.

Biomed Res Int. 2015;2015:289751. doi: 10.1155/2015/289751.

16.

Hypothermia and hypokalemia in a patient with diabetic ketoacidosis.

Saito O, Saito T, Sugase T, Kusano E, Nagata D.

Saudi J Kidney Dis Transpl. 2015 May-Jun;26(3):580-3. doi: 10.4103/1319-2442.157387.

17.

Identifying Residents' Health Issues Six Weeks after the Great East Japan Earthquake.

Teramoto C, Nagata S, Okamoto R, Suzuki R, Kishi E, Nomura M, Jojima N, Nishida M, Koide K, Kusano E, Iwamoto S, Murashima S.

Public Health Nurs. 2015 Nov-Dec;32(6):654-61. doi: 10.1111/phn.12201.

PMID:
26017670
18.

Shoulder pad sign and asymptomatic hypercalcemia in a patient with end-stage kidney disease.

Izawa S, Akimoto T, Ikeuchi H, Kusano E, Nagata D.

Clin Med Insights Case Rep. 2015 Mar 15;8:27-31. doi: 10.4137/CCRep.S21848.

19.

High salt intake is associated with renal involvement in Japanese patients with type 2 diabetes mellitus.

Kawabata N, Kawamura T, Utsunomiya K, Kusano E.

Intern Med. 2015;54(3):311-7. doi: 10.2169/internalmedicine.54.2464.

20.

Characterization of the cation-binding capacity of a potassium-adsorption filter used in red blood cell transfusion.

Suzuki T, Muto S, Miyata Y, Maeda T, Odate T, Shimanaka K, Kusano E.

Ther Apher Dial. 2015 Jun;19(3):288-95. doi: 10.1111/1744-9987.12278.

PMID:
25656422

Supplemental Content

Loading ...
Support Center